全球因艾滋病毒导致的癌症负担:全球发病率分析
Yue Huang1, Damien Georges1, Harriet Rumgay2
1Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
The Lancet. Global health
|August 22, 2025
概括
在2022年,艾滋病毒占全球癌症病例的0.4%,区域差异很大. 宫癌,卡波西肉瘤和非霍奇金淋巴瘤是最常见的与艾滋病毒相关的癌症,特别是在非洲.
科学领域:
- 全球健康
- 流行病学
- 癌症学
背景情况:
- 由于艾滋病毒诱导的免疫抑制,艾滋病毒感染者 (PLWH) 面临感染相关癌症的风险增加.
- 全球癌症负担的具体归因于艾滋病毒之前没有估计.
研究的目的:
- 估计2022年因艾滋病毒而造成的全球和区域癌症负担.
- 分析与艾滋病毒相关的癌症的地理差异.
主要方法:
- 评估了9种与艾滋病毒感染相关的癌症类型.
- 使用元分析和艾滋病毒流行数据计算人口归因分数 (PAF).
- 将PAF应用于全球癌症发病率数据 (GLOBOCAN 2022) 以确定可归因于HIV的癌症病例和发病率.
主要成果:
- 在2022年,估计有81,300例癌症 (占全球总数的0.4%) 是由艾滋病毒引起的.
- 宫癌,卡波西肉瘤和非霍奇金淋巴瘤是主要的与艾滋病毒有关的癌症.
- 非洲承担了最大的负担, 超过70%的病例发生在那里,
结论:
- 全球因艾滋病毒导致的癌症负担显著变化.
- 结果可以指导特定区域的艾滋病毒控制策略和癌症干预措施,如疫苗接种和查,以减轻PLWH的癌症风险.
更多相关视频
23:56Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
16.8K
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
31.7K
相关概念视频
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Prevalence and Incidence
802
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
802
Sexually Transmitted Infections
411
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
411
Mechanisms of Retrovirus-induced Cancers
5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
